HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beauty (Cosmetics)

Set Alert for Beauty (Cosmetics)

Regulation/Legislation Explore this Topic

Latest From Beauty & Regulation

Califf Clears First Senate Hurdle, But FDA Decision On Abortion Pill May Complicate Final Confirmation

Republican opposition to Califf over agency’s recent move to relax its Mifeprex restrictions is ominous since, in order be confirmed as commissioner, he’ll need enough GOP votes to make up for Democratic opposition over his opioid track record and connections to pharma industry.

FDA Leadership

US FDA Says White Paper Could Inform Rulemaking For Cosmetic Talc-Asbestos Testing

Formed by the FDA in fall 2018 and convened in early 2020 for a public meeting, the Interagency Working Group on Asbestos in Consumer Products maintains that electron microscopy should be a first-line method for detecting asbestos in cosmetic talc and talc-containing products, and that labs should report elongate mineral particles beyond those classically understood as asbestos.

United States Cosmetic Ingredients

PCPC, CHPA Ask US FDA To Defer Final Rulemaking On Sunscreen Actives In GRASE Limbo

Industry continues working to support updated GRASE findings for UV filters avobenzone, homosalate, octinoxate, octisalate, octocrylene, oxybenzone, ensulizole and meradimate, which the FDA categorized more than two years ago as lacking data, a position it reprised in 2021 under its overhauled OTC monograph system.

United States FDA
See All

Latest From Beauty & Legislation

Manchin’s Build Back Better Battle Could Sink Restoring FTC Monetary Relief Authority

Members of Congress in favor of giving FTC authority to impose monetary relief orders against firms linked to false advertising likely were caught off guard when West Virginia Democrat said he wouldn’t vote for legislation with $2.2 trillion for climate change, tax and social programs that President Biden made a primary plank of his Capitol Hill strategy and that the House passed in November.

Ad Complaints Consumer

Oregon’s Proposed Limits On Cannabinoid Sales Hit Hemp Trade Group As 'Dangerous Precedent'

US Hemp Roundtable submits comments on proposed rule as well as surveys hemp and cannabinoid product market stakeholders “to demonstrate the devastating impact the new rules would have on farmers, retailers and consumers.”

Cannabidiol CBD Dietary Supplements

With Data Coming Slowly On Cannabis, Hemp Ingredients, FDA Launches ‘Acceleration Plan’

Cannabis-Derived Products Data Acceleration Plan aims to avoid same conclusion already found in FDA's more-than two-year search for information on using cannabis ingredients in supplements, food and beverages and personal care topicals: too little is available to determine safety.

Dietary Supplements FDA
See All

Latest From Beauty & Legal Issues

Manchin’s Build Back Better Battle Could Sink Restoring FTC Monetary Relief Authority

Members of Congress in favor of giving FTC authority to impose monetary relief orders against firms linked to false advertising likely were caught off guard when West Virginia Democrat said he wouldn’t vote for legislation with $2.2 trillion for climate change, tax and social programs that President Biden made a primary plank of his Capitol Hill strategy and that the House passed in November.

Ad Complaints Consumer

P&G Recalls Secret, Old Spice Sprays For Benzene Contamination As Class Actions Mount Around US

There’s an increasingly familiar pattern to leading personal-care manufacturers’ benzene troubles in the states: Independent testing lab Valisure flags their product(s) as contaminated with the carcinogen; class actions file in federal courts; and, frequently, recalls are undertaken “out of an abundance of caution.”

United States Legal Issues

Valisure’s Findings Of Benzene In Body Sprays Suggest Ongoing Aerosol Propellant Problem

Hydrocarbon-based propellants can harbor trace levels of benzene, among other impurities, when quality controls are insufficient. Leading brands’ antiperspirant and deodorant body sprays are the latest aerosol personal-care products identified by independent laboratory Valisure as contaminated with the carcinogen.

United States Ingredients
See All

Latest From Beauty & Deals

More ‘Visibility’ For Investors Into Standalone J&J Consumer Business Needed For Growth – CEO

“There's been not enough investors' visibility to our consumer health business," recently promoted CEO Duato says at JP Morgan conference, With separate business, "investors are going to see the strength of our consumer health business, the number of iconic brands, the global scale and our penetration, the unique relationship that consumer have with our brands."

OTC Drugs M & A

German Women's Supplements Specialist InnoNature Secures Private-Equity Backing

Germany's Innonature - which develops and markets supplements, superfoods and cosmetics for women - has been snapped up by Northern European private-equity firm Verdane.

Deals Europe

EU Business News: Nestlé Cuts L'Oréal Stake, Stada Sets Up In Sweden

The latest news from Europe's health, beauty and wellness markets: Nestlé is reducing its stake in L'Oréal to fund an expanded share buyback program; and Stada has opened in office in Sweden to manage the distribution and marketing of a portfolio of well-established Sanofi brands.

Europe Business Strategies
See All

Latest From Beauty & Business Strategies

Floss By Any Other Name Would Sell In Same Category – BBB National Programs Appeals Panel

NARB panel concluded #1 claims challenged by Oral-B floss products marketer P&G aren’t supported by acceptable evidence that the type of product the claim referenced – flossers  – “is recognized as a consumer-relevant category."

OTC Devices Ad Complaints

L’Oréal Tackles Age-Old Problems With Home Hair Color, Spurred By Pandemic Demand

The French beauty giant plans to launch its Colorsonic at-home hair color device with oscillating nozzle in early 2023. L’Oreal showcased the product, along with a breakthrough hair color “reader” and custom mixing system for salon use, at the CES 2022 tech show in Las Vegas.

Beauty Innovation

More ‘Visibility’ For Investors Into Standalone J&J Consumer Business Needed For Growth – CEO

“There's been not enough investors' visibility to our consumer health business," recently promoted CEO Duato says at JP Morgan conference, With separate business, "investors are going to see the strength of our consumer health business, the number of iconic brands, the global scale and our penetration, the unique relationship that consumer have with our brands."

OTC Drugs M & A
See All

Latest From Beauty & Sales & Earnings

Coty’s FY 2023 Will Be ‘Year Of Skin Care’; Reinstated ‘Powerhouse’ Says Growth Engines Are Fired

Doubts about Coty’s “viability” have melted away with the return to growth of its Consumer Beauty division and momentum in its burgeoning skin-care and prestige cosmetics businesses. Coty now aims to beat the market with 6% to 8% compound annual revenue growth from fiscal 2022 through 2025.

Beauty Business Strategies

E.l.f. Cosmetics Will Be ‘100% Clean’ Going Into 2022; Q2 Sales Up 27% To $92M

E.l.f.’s core consumer proposition continues to focus on quality, innovative products at accessible prices, but the company also has been working to strengthen its “clean” credentials, reformulating more than 350 SKUs in recent months to ensure that its namesake brand is “100% clean” by year-end.

United States Sales & Earnings

Prestige Links Sales Growth To Retailer, Consumer Supply-Chain Fears

Retailer and consumer stockpiling in fear of supply chain disruptions drive double digit consumption growth for Prestige Consumer Healthcare’s Dramamine, Nix, Hydralyte and cough/cold brands. Brands drove total sales up 10.5% excluding impact of Akorn, to $12.4m in latest quarter. 

Coronavirus COVID-19 OTC Drugs
See All

Marketing Explore this Topic

Latest From Beauty & Launches

Cosmetic And Personal Care Trademark Review 11 January, 2022

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Cosmetics Launches

L’Oréal Tackles Age-Old Problems With Home Hair Color, Spurred By Pandemic Demand

The French beauty giant plans to launch its Colorsonic at-home hair color device with oscillating nozzle in early 2023. L’Oreal showcased the product, along with a breakthrough hair color “reader” and custom mixing system for salon use, at the CES 2022 tech show in Las Vegas.

Beauty Innovation

Cosmetic And Personal Care Trademark Review 4 January, 2022

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Cosmetics Launches
See All

Latest From Beauty & Cosmetic Ingredients

US FDA Says White Paper Could Inform Rulemaking For Cosmetic Talc-Asbestos Testing

Formed by the FDA in fall 2018 and convened in early 2020 for a public meeting, the Interagency Working Group on Asbestos in Consumer Products maintains that electron microscopy should be a first-line method for detecting asbestos in cosmetic talc and talc-containing products, and that labs should report elongate mineral particles beyond those classically understood as asbestos.

United States Cosmetic Ingredients

Cosmetic And Personal Care Trademark Review 11 January, 2022

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Cosmetics Launches

Cosmetic And Personal Care Trademark Review 4 January, 2022

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Cosmetics Launches
See All

Latest From Beauty & Ad Complaints

Floss By Any Other Name Would Sell In Same Category – BBB National Programs Appeals Panel

NARB panel concluded #1 claims challenged by Oral-B floss products marketer P&G aren’t supported by acceptable evidence that the type of product the claim referenced – flossers  – “is recognized as a consumer-relevant category."

OTC Devices Ad Complaints

Manchin’s Build Back Better Battle Could Sink Restoring FTC Monetary Relief Authority

Members of Congress in favor of giving FTC authority to impose monetary relief orders against firms linked to false advertising likely were caught off guard when West Virginia Democrat said he wouldn’t vote for legislation with $2.2 trillion for climate change, tax and social programs that President Biden made a primary plank of his Capitol Hill strategy and that the House passed in November.

Ad Complaints Consumer

Perrigo Picks At Industry Self-Regulation Group Measuring Flosser Market By Units, Not Sales

NAD says “equivalized” sales data Perrigo submitted to support claim didn’t provide an accurate measure of flosser product category; instead, “un-equivalized” data P&G submitted were accurate measure. Perrigo counters that the decision conflated separate product categories as well as dismissed appropriate data.

Ad Complaints OTC Devices
See All
UsernamePublicRestriction

Register